Chemical Name: 4-(2-(4-(Benzyloxy)phenylacetamido)-1-(3-chloro-[1,1-biphenyl]-4-carbonyl)piperidine-4-carboxylic acid. Alternate Names: 1-[4-(3-Chlorophenyl)benzoyl]-4-[[2-(4-phenylmethoxyphenyl)acetyl]amino]piperidine-4-carboxylic acid
GPR34 antagonist
Molekulargewicht:
583.08
Reinheit:
>98% by HPLC NMR (Conforms)
Formulierung:
White solid
Formel:
C34H31ClN2O5
Anwendungsbeschreibung:
YL-365 is a potent (IC50 = 17 nM) and selective antagonist of GPR34, a GPCR for lysophosphatidylserine.1 GPR34 is highly expressed in various immune cells and has been implicated in several types of cancer.2 YL-365 showed no activity against various other GPCRs as well as a panel of 378 kinases. It alleviated hyperalgesia in a mouse model of neuropathic pain via downregulation of iNOS in M1 microglia without any toxicity.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten